Introduction to ACE Inhibitors

Angiotensin-Converting Enzyme Inhibitors Introduction Angiotensin-converting enzyme (ACE) inhibitors are a class of medications that lower blood pressure and reduce the workload on the heart. They work by blocking a crucial enzyme in the body's blood pressure regulation system. Understanding how these drugs function is essential for recognizing their therapeutic benefits and their potential side effects. How ACE Inhibitors Work The primary mechanism of ACE inhibitors is straightforward: they block the enzyme angiotensin-converting enzyme, which normally performs a critical step in blood pressure regulation. Specifically, ACE converts angiotensin I into angiotensin II. Angiotensin II is a potent vasoconstrictor—meaning it causes blood vessels to narrow and tighten. When blood vessels constrict, blood pressure rises. By blocking the conversion to angiotensin II, ACE inhibitors allow angiotensin I to accumulate harmlessly while preventing the formation of this powerful constrictor. With less angiotensin II available, blood vessels can relax and dilate, lowering blood pressure overall. Effects on the Renin-Angiotensin-Aldosterone System To fully appreciate how ACE inhibitors work, it's helpful to understand the broader system they affect: the renin-angiotensin-aldosterone system (RAAS). When ACE is blocked and angiotensin II levels drop, several important changes occur: Vasodilation and reduced peripheral resistance. With less angiotensin II circulating, the smooth muscle in artery walls relaxes. This vasodilation allows blood to flow more easily through vessels, reducing peripheral resistance and blood pressure. Decreased aldosterone secretion. Angiotensin II normally stimulates the adrenal glands to release aldosterone, a hormone that tells the kidneys to reabsorb sodium and water. When ACE inhibitors reduce angiotensin II, aldosterone secretion drops. This means the kidneys excrete more sodium and water, which decreases blood volume and further lowers blood pressure. Reduced sympathetic nervous system activity. Angiotensin II also activates the sympathetic nervous system, which increases heart rate and constricts blood vessels. By lowering angiotensin II levels, ACE inhibitors dampen this sympathetic activity, contributing to a slower heart rate and lower blood pressure. Together, these effects make ACE inhibitors powerful blood pressure-lowering agents. Clinical Uses ACE inhibitors are beneficial in several cardiovascular conditions: Hypertension. ACE inhibitors are first-line therapy for high blood pressure. They effectively lower blood pressure while also protecting the heart from the damage that sustained hypertension causes. This makes them excellent choices for long-term management. Heart failure. In patients with weakened hearts, ACE inhibitors reduce both preload (the amount of blood stretching the heart before it contracts) and afterload (the resistance the heart must pump against). By reducing the workload on the failing heart, these drugs help it function more effectively and slow disease progression. After myocardial infarction (heart attack). Following a heart attack, the damaged heart often undergoes pathological remodeling—a harmful process where the heart wall thins and enlarges abnormally. ACE inhibitors prevent this remodeling and reduce the risk of future heart problems. Diabetic kidney disease. Diabetes damages the small blood vessels in the kidneys, leading to kidney disease. ACE inhibitors protect the kidneys by lowering the pressure within the glomerulus (the blood filtering unit), which slows the progression of kidney damage even beyond their blood pressure-lowering effects. Representative Drugs and Pharmacokinetics Several ACE inhibitors are commonly prescribed, and they differ in how long they remain active in the body: Captopril. This is a short-acting ACE inhibitor that must be taken multiple times daily. It's one of the oldest drugs in this class and is useful when rapid blood pressure reduction is needed. Enalapril. Unlike captopril, enalapril is a "prodrug"—it's inactive when taken and must be converted to its active form by the liver. Once activated, it has intermediate duration, though it still requires twice-daily dosing for most patients. Lisinopril. This drug has a long half-life, meaning it remains active in the body for an extended period. This allows once-daily dosing, which improves patient adherence and convenience. <extrainfo> shows the chemical structure of captopril, illustrating its unique thiol (-SH) group and pyrrolidine ring structure. </extrainfo> Common Side Effects Although ACE inhibitors are generally well-tolerated, several side effects deserve attention: Persistent dry cough. The most frequent side effect is a dry, ticklish cough that affects 10-20% of patients. This occurs because ACE also breaks down bradykinin, a chemical that causes inflammation and bronchial constriction. When ACE is inhibited, bradykinin accumulates in the lungs, triggering the cough. This side effect is bothersome but not dangerous, and it typically resolves if the drug is discontinued. Angioedema. While less common than cough, angioedema is more serious. It causes swelling of the lips, tongue, or throat—sometimes so severe it blocks the airway. Like the cough, angioedema results from bradykinin accumulation. It can develop anytime during treatment, even months after starting the drug, and requires immediate medical attention. Patients who develop angioedema must discontinue ACE inhibitors permanently. Hyperkalemia. ACE inhibitors can elevate blood potassium levels. This occurs because reduced aldosterone impairs the kidneys' ability to excrete potassium. In healthy individuals with normal kidney function, this is usually minor, but patients with kidney disease or those taking potassium supplements are at higher risk for dangerously high potassium levels. Worsening kidney function. In patients whose kidneys depend heavily on the pressure provided by angiotensin II (such as those with severe renal artery stenosis), ACE inhibitors can paradoxically worsen kidney function by reducing glomerular filtration pressure too much. Monitoring and Precautions Because of the potential for serious complications, careful monitoring is essential when patients begin ACE inhibitor therapy: Blood pressure monitoring. Clinicians measure blood pressure regularly after starting an ACE inhibitor to ensure the dose is adequate and the patient tolerates the drug. Laboratory tests. Serum creatinine (a marker of kidney function) and electrolyte levels—particularly potassium—must be checked. These baseline measurements are obtained before treatment begins, then rechecked after 1-2 weeks to catch any deterioration in kidney function or elevation in potassium early. Contraindications. Patients with a prior history of angioedema should never receive an ACE inhibitor, as the risk of recurrence is substantial. Additionally, caution is warranted in patients with severe renal artery stenosis or bilateral renal artery disease, where the kidneys depend critically on angiotensin II's effect to maintain filtration pressure. Drug interactions. Combining ACE inhibitors with potassium-sparing diuretics, potassium supplements, or NSAIDs increases the risk of hyperkalemia and requires careful monitoring.